# Safe Pro Group Inc.: overview

SPAI · Nasdaq · CIK 2011208 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spai.md) · [Financials](/companies/spai/financials.md) · [Filings](/companies/spai/filings.md) · [Insiders](/companies/spai/insiders.md)

Latest reported revenue: [$1.3m](/filings/0001493152-26-038289.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038289).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [331](/filings/0001493152-25-023458.md) | [888 d](/filings/0001493152-26-014181.md) | [185](/filings/0001493152-26-023469.md) | [92.8](/filings/0001493152-26-038289.md) | [101](/filings/0001493152-25-023458.md) | [228 d](/filings/0001493152-26-014181.md) | [1,220](/filings/0001493152-26-023469.md) | [1,332](/filings/0001493152-26-038289.md) |
| Gross margin | % | [40.6%](/filings/0001493152-25-023458.md) | [52.2% d](/filings/0001493152-26-014181.md) | [33.3%](/filings/0001493152-26-023469.md) | [34.0%](/filings/0001493152-26-038289.md) | [33.1%](/filings/0001493152-25-023458.md) | [33.1% d](/filings/0001493152-26-014181.md) | [68.1%](/filings/0001493152-26-023469.md) | [64.0%](/filings/0001493152-26-038289.md) |
| Operating margin | % | [(1070.9%)](/filings/0001493152-25-023458.md) | [(157.9%) d](/filings/0001493152-26-014181.md) | [(2167.6%)](/filings/0001493152-26-023469.md) | [(2073.6%)](/filings/0001493152-26-038289.md) | [(4148.6%)](/filings/0001493152-25-023458.md) | [(1936.2%) d](/filings/0001493152-26-014181.md) | [(239.1%)](/filings/0001493152-26-023469.md) | [(245.6%)](/filings/0001493152-26-038289.md) |
| Net margin | % | [(1114.3%)](/filings/0001493152-25-023458.md) | [(155.9%) d](/filings/0001493152-26-014181.md) | [(2145.5%)](/filings/0001493152-26-023469.md) | [(2064.1%)](/filings/0001493152-26-038289.md) | [(4940.1%)](/filings/0001493152-25-023458.md) | [(1507.6%) d](/filings/0001493152-26-014181.md) | [(228.9%)](/filings/0001493152-26-023469.md) | [(237.9%)](/filings/0001493152-26-038289.md) |
| Diluted EPS | $ per share | [(0.34)](/filings/0001493152-25-023458.md) | not reported | [(0.27)](/filings/0001493152-26-023469.md) | [(0.13)](/filings/0001493152-26-038289.md) | [(0.29)](/filings/0001493152-25-023458.md) | not reported | [(0.14)](/filings/0001493152-26-023469.md) | [(0.15)](/filings/0001493152-26-038289.md) |
| Free cash flow | $k | [(1,909) d](/filings/0001493152-25-023458.md) | [(1,040) d](/filings/0001493152-26-014181.md) | [(960)](/filings/0001493152-26-023469.md) | [(1,046) d](/filings/0001493152-26-038289.md) | [(1,570) d](/filings/0001493152-25-023458.md) | [(2,690) d](/filings/0001493152-26-014181.md) | [(1,226)](/filings/0001493152-26-023469.md) | [(2,938) d](/filings/0001493152-26-038289.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $k | [918](/filings/0001641172-25-001383.md) | [2,169](/filings/0001493152-26-014181.md) | [607](/filings/0001493152-26-014181.md) |
| Gross margin | % | [33.9%](/filings/0001641172-25-001383.md) | [41.8%](/filings/0001493152-26-014181.md) | [33.3%](/filings/0001493152-26-014181.md) |
| Operating margin | % | [(687.2%)](/filings/0001641172-25-001383.md) | [(329.7%)](/filings/0001493152-26-014181.md) | [(2397.6%)](/filings/0001493152-26-014181.md) |
| Net margin | % | [(688.1%)](/filings/0001641172-25-001383.md) | [(342.5%)](/filings/0001493152-26-014181.md) | [(2360.8%)](/filings/0001493152-26-014181.md) |
| Diluted EPS | $ per share | [(0.79)](/filings/0001641172-25-001383.md) | [(0.70)](/filings/0001493152-26-014181.md) | [(0.85)](/filings/0001493152-26-014181.md) |
| Free cash flow | $k | [(2,034)](/filings/0001641172-25-001383.md) | [(4,159)](/filings/0001493152-26-014181.md) | [(6,265)](/filings/0001493152-26-014181.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/spai/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.4m | 563,837 |  | Added +110,780 |
| [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $1.3m | 306,735 |  | Unchanged |
| [PERKINS CAPITAL MANAGEMENT INC](/funds/884300.md) | 2026-06-30 | $998.1k | 230,500 |  | Reduced −750 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $637.0k | 147,046 |  | Reduced −3,040 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $604.3k | 139,551 |  | New +139,551 |
| [TUDOR INVESTMENT CORP ET AL](/funds/923093.md) | 2026-06-30 | $560.6k | 129,459 |  | Reduced −96,037 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $328.8k | 75,926 |  | Added +10,294 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $317.2k | 73,258 |  | Added +13,004 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $210.5k | 48,615 |  | Unchanged |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $193.5k | 44,688 |  | Reduced −17,340 |

## Recent filings

[All 114 filings](/companies/spai/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 12:00 ET | [8-K](/filings/0001437749-26-032265.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-032265 |
| 2026-08-25 | 11:00 ET | [8-K](/filings/0001493152-26-039954.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039954 |
| 2026-08-18 | 13:54 ET | [8-K](/filings/0001493152-26-038924.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038924 |
| 2026-08-14 | 20:01 ET | [10-Q](/filings/0001493152-26-038289.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038289 |
| 2026-08-14 | 12:44 ET | [8-K](/filings/0001493152-26-038010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038010 |
| 2026-08-06 | 11:24 ET | [8-K](/filings/0001493152-26-036259.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036259 |
| 2026-08-03 | 13:28 ET | [8-K](/filings/0001493152-26-035761.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035761 |
| 2026-06-23 | 20:00 ET | [8-K](/filings/0001493152-26-029775.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029775 |
| 2026-06-02 | 12:41 ET | [8-K](/filings/0001493152-26-026778.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026778 |
| 2026-05-29 | 20:15 ET | [8-K](/filings/0001493152-26-026373.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-026373 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014181.md), filed Mar 31, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2011208
- Tickers: SPAI
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.
